Click here to access our investor documents
First biopharmaceutical company leveraging established, accelerated pathways to psychedelic-assisted therapies for patients with urgent, unmet needs across the UK, EU and other healthcare networks
Developing scalable solutions to generate clinical data through access to existing patient pools within world-leading research and clinical networks
Initial focus on treating cancer-related anxiety and depression before moving into broader mental health indications
© 2022 Albert Labs. All Rights Reserved
We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.
If you would like support or more information around making an investment, please contact firstname.lastname@example.org